KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Interest Coverage Ratio: 2010-2020

Historic Interest Coverage Ratio for Nektar Therapeutics (NKTR) over the last 10 years, with Jun 2020 value amounting to -120.11.

  • Nektar Therapeutics' Interest Coverage Ratio fell 466.17% to -120.11 in Q2 2020 from the same period last year, while for Jun 2020 it was -23.71, marking a year-over-year decrease of 17.35%. This contributed to the annual value of -62.05 for FY2020, which is 200.50% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Interest Coverage Ratio of -120.11 as of Q2 2020, which was down 457.61% from -21.54 recorded in Q1 2020.
  • Over the past 5 years, Nektar Therapeutics' Interest Coverage Ratio peaked at 180.80 during Q2 2018, and registered a low of -120.11 during Q2 2020.
  • For the 3-year period, Nektar Therapeutics' Interest Coverage Ratio averaged around -9.64, with its median value being -19.36 (2018).
  • As far as peak fluctuations go, Nektar Therapeutics' Interest Coverage Ratio slumped by 5,977.31% in 2016, and later skyrocketed by 2,066.60% in 2018.
  • Over the past 5 years, Nektar Therapeutics' Interest Coverage Ratio (Quarterly) stood at -5.79 in 2016, then increased by 26.33% to -4.27 in 2017, then plummeted by 334.10% to -18.52 in 2018, then fell by 9.05% to -20.20 in 2019, then slumped by 466.17% to -120.11 in 2020.
  • Its last three reported values are -120.11 in Q2 2020, -21.54 for Q1 2020, and -20.20 during Q4 2019.